DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company focused on innovative approaches to driving durable behavior change in chronic disease, to positively impact health outcomes and cost of care. Dario creates durable behavior change in chronic conditions. For individuals facing the challenges of diabetes, prediabetes, hypertension, obesity, and other chronic conditions, Dario delivers highly personalized digital interactions, actionable data, engaging digital tools and easy to use monitoring devices plus human support. Combined, these touch points make doing the "right thing the easy thing" by encouraging proactive, positive behavior changes that lead to improved health outcomes. Dario chronic condition digital therapeutics solution and the MyDario™ mobile app is loved and recommended by close to 100,000 users around the globe--with a 4.9 star rating across 11,000 reviews on the Apple App Store, and world-class Net Promoter Score (NPS) of 77.

Kiio enhances your healthcare ecosystem so that people get access to the right MSK care when and where they need it. Kiio is a fit for over 80% of people with MSK issues. And for the rest, we provide immediate connection to appropriate care within your network. 

With Kiio, member can start immediately, access therapy 24/7, and get personalized care that is simple, easy, and effective. Kiio helps members achieve their pain management goals – from alleviating an acute episode to preventing flare-ups to managing chronic pain – in the comfort of their home with convenient 7-minute sessions. 

Kiio is proven to prevent urgent care visits and unnecessary diagnostics, treatments, opioid prescriptions, and surgeries. Kiio’s digital approach ensures consistent, evidence-based first-line care.

Kiio is focused on the design, development, manufacture and distribution of objective measurement and tracking devices and enterprise software solutions, with a current focus on lower back pain